{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:54:41Z","timestamp":1787500481538,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41440-022-01055-3","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T21:02:25Z","timestamp":1665781345000},"page":"40-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Angiotensin II-induced a steeper blood pressure elevation in IL-23 receptor-deficient mice: Role of interferon-\u03b3-producing T cells"],"prefix":"10.1038","volume":"46","author":[{"given":"Brandon G.","family":"Shokoples","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanne S.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Berillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Oukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto L.","family":"Schiffrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"1055_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA 2017;317:165\u201382.","journal-title":"JAMA"},{"key":"1055_CR2","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2012","unstructured":"Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224\u201360.","journal-title":"Lancet"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(19)31145-6","volume":"394","author":"B Zhou","year":"2019","unstructured":"Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639\u201351.","journal-title":"Lancet"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1161\/CIRCULATIONAHA.109.906164","volume":"120","author":"AV Chobanian","year":"2009","unstructured":"Chobanian AV. Impact of nonadherence to antihypertensive therapy. Circulation 2009;120:1558\u201360.","journal-title":"Circulation"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/bph.14427","volume":"176","author":"A Caillon","year":"2019","unstructured":"Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharm. 2019;176:1818\u201328.","journal-title":"Br J Pharm"},{"key":"1055_CR6","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1161\/CIRCULATIONAHA.116.027058","volume":"135","author":"A Caillon","year":"2017","unstructured":"Caillon A, Mian MOR, Fraulob-Aquino JC, Huo KG, Barhoumi T, Ouerd S, et al. gammadelta T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury. Circulation 2017;135:2155\u201362.","journal-title":"Circulation"},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11906-019-0907-1","volume":"21","author":"A Higaki","year":"2019","unstructured":"Higaki A, Caillon A, Paradis P, Schiffrin EL. Innate and innate-like immune system in hypertension and vascular injury. Curr Hypertens Rep. 2019;21:4.","journal-title":"Curr Hypertens Rep"},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.0810059106","volume":"106","author":"M Brandes","year":"2009","unstructured":"Brandes M, Willimann K, Bioley G, Levy N, Eberl M, Luo M, et al. Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci USA. 2009;106:2307\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41590-018-0094-2","volume":"19","author":"AC Kohlgruber","year":"2018","unstructured":"Kohlgruber AC, Gal-Oz ST, Lamarche NM, Shimazaki M, Duquette D, Koay H-F, et al. T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. Nat Immunol. 2018;19:464\u201374.","journal-title":"Nat Immunol"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","volume":"55","author":"MS Madhur","year":"2010","unstructured":"Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500\u20137.","journal-title":"Hypertension"},{"key":"1055_CR11","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","volume":"34","author":"S Karbach","year":"2014","unstructured":"Karbach S, Croxford AL, Oelze M, Sch\u00fcler R, Minwegen D, Wegner J, et al. Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease. Arteriosclerosis, Thrombosis, Vasc Biol. 2014;34:2658\u201368.","journal-title":"Arteriosclerosis, Thrombosis, Vasc Biol"},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/jch.12612","volume":"17","author":"W Yao","year":"2015","unstructured":"Yao W, Sun Y, Wang X, Niu K. Elevated serum level of interleukin 17 in a population with prehypertension. J Clin Hypertens (Greenwich). 2015;17:770\u20134.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat Rev Immunol. 2013;13:88\u2013100.","journal-title":"Nat Rev Immunol"},{"key":"1055_CR14","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.4049\/jimmunol.1700287","volume":"199","author":"A Muschaweckh","year":"2017","unstructured":"Muschaweckh A, Petermann F, Korn T. IL-1beta and IL-23 Promote Extrathymic Commitment of CD27(+)CD122(\u2212) gammadelta T Cells to gammadeltaT17 Cells. J Immunol. 2017;199:2668\u201379.","journal-title":"J Immunol"},{"key":"1055_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13098-016-0164-2","volume":"8","author":"M Schaalan","year":"2016","unstructured":"Schaalan M, Mohamed W, Rahmo R. Association of cardiac NT pro-beta-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation. Diabetol Metab Syndr. 2016;8:52.","journal-title":"Diabetol Metab Syndr"},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"e2020","DOI":"10.1155\/2020\/2369279","volume":"2020","author":"J Ye","year":"2020","unstructured":"Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, et al. The Expression of IL-12 family members in patients with hypertension and its association with the occurrence of carotid atherosclerosis. Mediators Inflamm 2020;2020:e2020.","journal-title":"Mediators Inflamm"},{"key":"1055_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/dna.2014.2573","volume":"33","author":"M Zhang","year":"2014","unstructured":"Zhang M, Cai ZR, Zhang B, Cai X, Li W, Guo Z, et al. Functional polymorphisms in interleukin-23 receptor and susceptibility to coronary artery disease. DNA Cell Biol. 2014;33:891\u20137.","journal-title":"DNA Cell Biol"},{"key":"1055_CR18","doi-asserted-by":"publisher","first-page":"dmm044107","DOI":"10.1242\/dmm.044107","volume":"13","author":"E Lee","year":"2020","unstructured":"Lee E, Kim N, Kang J, Yoon S, Lee HA, Jung H, et al. Activated pathogenic Th17 lymphocytes induce hypertension following high-fructose intake in Dahl salt-sensitive but not Dahl salt-resistant rats. Dis Model Mech. 2020;13:dmm044107.","journal-title":"Dis Model Mech"},{"key":"1055_CR19","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.4049\/jimmunol.0900732","volume":"182","author":"A Awasthi","year":"2009","unstructured":"Awasthi A, Riol-Blanco L, Jager A, Korn T, Pot C, Galileos G, et al. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol. 2009;182:5904\u20138.","journal-title":"J Immunol"},{"key":"1055_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cjca.2020.02.003","volume":"36","author":"EL Schiffrin","year":"2020","unstructured":"Schiffrin EL. How structure, mechanics, and function of the vasculature contribute to blood pressure elevation in hypertension. Can J Cardiol. 2020;36:648\u201358.","journal-title":"Can J Cardiol"},{"key":"1055_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jacbts.2016.07.009","volume":"1","author":"MA Saleh","year":"2016","unstructured":"Saleh MA, Norlander AE, Madhur MS. Inhibition of interleukin 17-A but not Interleukin-17F signaling lowers blood pressure and reduces end-organ inflammation in angiotensin II-induced hypertension. JACC Basic Transl Sci. 2016;1:606\u201316.","journal-title":"JACC Basic Transl Sci"},{"key":"1055_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/HYPERTENSIONAHA.114.04975","volume":"65","author":"NV Kamat","year":"2015","unstructured":"Kamat NV, Thabet SR, Xiao L, Saleh MA, Kirabo A, Madhur MS, et al. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-gamma\u2212\/\u2212 and interleukin-17A-\/- mice. Hypertension 2015;65:569\u201376.","journal-title":"Hypertension"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/HYPERTENSIONAHA.113.02620","volume":"63","author":"CF Krebs","year":"2014","unstructured":"Krebs CF, Lange S, Niemann G, Rosendahl A, Lehners A, Meyer-Schwesinger C, et al. Deficiency of the interleukin 17\/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension. Hypertension 2014;63:565\u201371.","journal-title":"Hypertension"},{"key":"1055_CR24","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","volume":"60","author":"L Marko","year":"2012","unstructured":"Marko L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ, et al. Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 2012;60:1430\u20136.","journal-title":"Hypertension"},{"key":"1055_CR25","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","volume":"121","author":"P Muranski","year":"2013","unstructured":"Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity. Blood 2013;121:2402\u201314.","journal-title":"Blood"},{"key":"1055_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/eji.202048627","volume":"50","author":"C L\u00fcckel","year":"2020","unstructured":"L\u00fcckel C, Picard FSR, Huber M. Tc17 biology and function: Novel concepts. Eur J Immunol. 2020;50:1257\u201367.","journal-title":"Eur J Immunol"},{"key":"1055_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/imr.12918","volume":"298","author":"GJ Fiala","year":"2020","unstructured":"Fiala GJ, Gomes AQ, Silva-Santos B. From thymus to periphery: Molecular basis of effector gammadelta-T cell differentiation. Immunol Rev. 2020;298:47\u201360.","journal-title":"Immunol Rev"},{"key":"1055_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jim.2004.07.006","volume":"293","author":"M Reddy","year":"2004","unstructured":"Reddy M, Eirikis E, Davis C, Davis HM, Prabhakar U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J Immunol Methods. 2004;293:127\u201342.","journal-title":"J Immunol Methods"},{"key":"1055_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F. CD69: From activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47:946\u201353.","journal-title":"Eur J Immunol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01055-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01055-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T19:09:04Z","timestamp":1672859344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01055-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-01055-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}